EGM
ALXN

Engineers Gate Manager’s Alexion Pharmaceuticals ALXN Stock Holding History

Engineers Gate Manager’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,040
Closed -$771K – 2206
2021
Q1 		$771K Buy
5,040
+3,340
+196% +$517K 0.04% 712
2020
Q4 		$266K Sell
1,700
-3,794
-69% -$488K 0.01% 1371
2020
Q3 		$629K Sell
5,494
-6,289
-53% -$678K 0.03% 860
2020
Q2 		$1.32M Buy
11,783
+4,754
+68% +$505K 0.07% 466
2020
Q1 		$631K Sell
7,029
-7,703
-52% -$756K 0.05% 652
2019
Q4 		$1.59M Sell
14,732
-22,541
-60% -$2.41M 0.07% 439
2019
Q3 		$3.65M Buy
37,273
+30,082
+418% +$3.39M 0.19% 151
2019
Q2 		$941K Buy
+7,191
New +$927K 0.05% 522
2016
Q3 		– Sell
-26,600
Closed -$3.11M – 810
2016
Q2 		$3.11M Buy
+26,600
New +$3.77M 0.22% 154
2015
Q4 		– Sell
-1,600
Closed -$250K – 841
2015
Q3 		$250K Buy
+1,600
New +$292K 0.02% 553
2015
Q2 		– Sell
-4,106
Closed -$712K – 1227
2015
Q1 		$712K Buy
+4,106
New +$743K 0.09% 396

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Engineers Gate Manager's ALXN Position: Q2 2021 in Review

Engineers Gate Manager sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 5,040 shares — an estimated $771K sold.

Engineers Gate Manager first reported a position in ALXN in Q1 2015 and held it in 11 quarters. The position peaked at $3.65M in Q3 2019. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Engineers Gate Manager reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 5,040 Alexion Pharmaceuticals shares in Q2 2021, an estimated $771K.
  • Engineers Gate Manager first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 11 quarters.
  • Engineers Gate Manager's Alexion Pharmaceuticals position peaked at $3.65M in Q3 2019.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.